These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38347756)

  • 1. Discovery and Identification of Novel 5-Hydroxy-4
    Xing G; Li Z; Zhi Z; Yi C; Zhang R; Yang H; Zhang Y; Lin B; Liu Y; Pan L; Cheng M
    J Med Chem; 2024 Feb; 67(4):2986-3003. PubMed ID: 38347756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of 8-(2-amino-1-hydroxyethyl)-6-hydroxy-1,4-benzoxazine-3(4H)-one derivatives as potent β
    Yi C; Xing G; Wang S; Li X; Liu Y; Li J; Lin B; Woo AY; Zhang Y; Pan L; Cheng M
    Bioorg Med Chem; 2020 Jan; 28(1):115178. PubMed ID: 31753798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of 5-(2-amino-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one derivatives as potent β
    Xing G; Pan L; Yi C; Li X; Ge X; Zhao Y; Liu Y; Li J; Woo A; Lin B; Zhang Y; Cheng M
    Bioorg Med Chem; 2019 Jun; 27(12):2306-2314. PubMed ID: 30392952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-Hydroxyquinolin-2(1H)-one analogues as potential β
    Xing G; Zhi Z; Yi C; Zou J; Jing X; Yiu-Ho Woo A; Lin B; Pan L; Zhang Y; Cheng M
    Eur J Med Chem; 2021 Nov; 224():113697. PubMed ID: 34273662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of 5-hydroxy-4H-benzo[1,4]oxazin-3-ones as beta2-adrenoceptor agonists.
    Hoenke C; Bouyssou T; Tautermann CS; Rudolf K; Schnapp A; Konetzki I
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6640-4. PubMed ID: 19875286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of β
    Ge X; Woo AY; Xing G; Lu Y; Mo Y; Zhao Y; Lan Y; Li J; Yan H; Pan L; Zhang Y; Lin B; Cheng M
    Eur J Med Chem; 2018 May; 152():424-435. PubMed ID: 29751236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights on the role of boron containing moieties in the design of new potent and efficient agonists targeting the β2 adrenoceptor.
    Soriano-Ursúa MA; Arias-Montaño JA; Correa-Basurto J; Hernández-Martínez CF; López-Cabrera Y; Castillo-Hernández MC; Padilla-Martínez II; Trujillo-Ferrara JG
    Bioorg Med Chem Lett; 2015 Feb; 25(4):820-5. PubMed ID: 25592716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and molecular modeling of 2-amino-2-phenylethanol derivatives as novel β
    Ge X; Mo Y; Xing G; Ji L; Zhao H; Chen J; He B; Chen X; Xing R; Li X; Zhao Y; Li J; Yan H; Woo AY; Zhang Y; Lin B; Pan L; Cheng M
    Bioorg Chem; 2018 Sep; 79():155-162. PubMed ID: 29751321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-acting β2-adrenoceptor agonist.
    Arnold N; Beattie D; Bradley M; Brearley A; Brown L; Charlton SJ; Fairhurst RA; Farr D; Fozard J; Fullerton J; Gosling M; Hatto J; Janus D; Jones D; Jordan L; Lewis C; Maas J; McCarthy C; Mercer M; Oakman H; Press N; Profit R; Schuerch F; Sykes D; Taylor RJ; Trifilieff A; Tuffnell A
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4341-7. PubMed ID: 25065493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting β2-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol.
    Aparici M; Gavaldà A; Ramos I; Carcasona C; Otal R; Fernández-Blanco JA; Montero JL; García VM; López R; De Alba J; Doe C; Puig C; Vilella D; Miralpeix M
    Eur J Pharmacol; 2016 Jan; 770():61-9. PubMed ID: 26656755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD.
    McKinnell RM; Klein U; Linsell MS; Moran EJ; Nodwell MB; Pfeiffer JW; Thomas GR; Yu C; Jacobsen JR
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2871-6. PubMed ID: 24835980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracheal relaxing effects and beta2 adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues.
    Suzuki H; Ueno A; Takei M; Sindo K; Miura T; Sakakibara M; Higa T; Fukamachi H
    Br J Pharmacol; 1999 Oct; 128(3):716-20. PubMed ID: 10516653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of olodaterol, a novel inhaled beta2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models.
    Bouyssou T; Casarosa P; Naline E; Pestel S; Konetzki I; Devillier P; Schnapp A
    J Pharmacol Exp Ther; 2010 Jul; 334(1):53-62. PubMed ID: 20371707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abediterol (LAS100977), an inhaled long-acting β
    Ramos I; Aparici M; Letosa M; Puig C; Gavaldà A; Huerta JM; Espinosa S; Vilella D; Miralpeix M
    Eur J Pharmacol; 2018 Jan; 819():89-97. PubMed ID: 29183838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy.
    Bouyssou T; Hoenke C; Rudolf K; Lustenberger P; Pestel S; Sieger P; Lotz R; Heine C; Büttner FH; Schnapp A; Konetzki I
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1410-4. PubMed ID: 20096576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    Baker JG
    Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of (a Combination of) the Beta
    Maarsingh H; Oldenburger A; Han B; Zuidhof AB; Elzinga CRS; Timens W; Meurs H; Sopi RB; Schmidt M
    Cells; 2021 May; 10(5):. PubMed ID: 34069899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
    Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties.
    Hegde SS; Hughes AD; Chen Y; Steinfeld T; Jasper JR; Lee TW; McNamara A; Martin WJ; Pulido-Rios MT; Mammen M
    J Pharmacol Exp Ther; 2014 Oct; 351(1):190-9. PubMed ID: 25100753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.